FIS 2020: Federation Of Infection Societies Conference 2020
9 - 11 November 2020 Online
The event brings together societies across the UK with interests in infectious diseases, clinical microbiology, biomedical science and infection control. The FIS societies are currently planning an engaging and interactive programme which will provide current research from a multitude of world experts in the field.
The full programme will be announced in September 2020.
Call for Abstracts
The abstract submission portal is now open for FIS/HIS International 2020 online.
By having a virtual poster or oral presentation accepted for FIS/HIS International 2020 you will be able to showcase your research, discuss your findings with international colleagues, and enhance your CV. You can submit under a huge range of topics, with those who have abstracts accepted playing a key role in conference.
The closing date for abstracts is Friday 4 September (23:59 BST)
To submit an abstract click here
Barnett Christie Lecture
Each year the BIA invites applications to deliver this highly prestigious lecture at the Conference of the Federation of Infection Societies. Doctors and scientists who have not yet reached consultant, senior lecturer or top grade scientist status are eligible to compete.
In addition to presenting this BIA lecture, the award winner will receive £500 and full sponsorship to attend the FIS Conference.
Further information on application coming soon.
The Scientific Organising Committee is made up of representatives from BIA, BSAC, HIS, SGM, Clinical Virology Network, UK Clinical Pharmacy Association Infection Management Group, IPS, Welsh Microbiology Association, BHIVA and the Children’s HIV Association.
FIS 2019 (Edinburgh) was hosted by the Microbiology Society
FIS 2018 (Newcastle) was hosted by the BIA
FIS 2017 (Birmingham) was hosted by BSAC
FIS 2016 (Edinburgh) was hosted by HIS
FIS 2015 (Glasgow) was hosted by the Society for General Microbiology. The theme was “Tackling infection beyond 2015″ with sessions to highlight that the post-antimicrobial era may stay a concern rather than become a reality.